A short peptide eluted from the H-2Kb molecule of a polyomavirus-positive tumor corresponds to polyomavirus large T antigen peptide at amino acids 578 to 585 and induces polyomavirus-specific immunity

Journal of Virology

Volumn 70, Issue 5, 1996, Pages 3093-3097

  Berke, Zsofia ^a   Palmer, Sarah ^a,c   Bergman, Tomas ^b   Wester, Daniele ^a   Svedmyr, Jonathan ^a   Linder, Stig ^a   Jörnvall, Hans ^b   Dalianis, Tina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS LARGE T ANTIGEN;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL SPECIFICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOGENICITY; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; POLYOMA VIRUS; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VIROGENESIS; VIRUS INDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS; IMMUNITY; LYMPHOMA, T-CELL; MICE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; PEPTIDE FRAGMENTS; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR VIRUS INFECTIONS; VIRAL VACCINES;

EID: 0029878117     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.5.3093-3097.1996     Document Type: Article

References (34)

1. Aichele, P., H. Hengartner, R. M. Zinkemagel, and M. Schulz. 1990. Anti-viral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J. Exp. Med. 171:1815-1820.
2. Allison, A. C. 1980. Immune responses to polyoma virus and polyoma virus induced tumors, p. 481-487. In G. Klein (ed ), Viral oncology. Raven Press, New York.
3. Bergman, T., M. Carlquist, and H. Jörnvall. 1986. Amino acid analysis by high performance liquid chromatography of phenylthiocarbamyl derivatives, p. 45-55. In B. Wittmann-Liebold, J. Salnikow, and V. A. Erdmann (ed.), Advanced methods in protein microscquence analysis. Springer. Berlin.
4. Bergman, T., and H. Jörnvall. 1987. Electroblotting of individual polypeptides from SDS-polyacrylamide gels for direct sequence analysis. Eur. J. Biochem. 169:9-12.
5. Berke, Z., and T. Dalianis. 1993. Persistence of polyomavirus in mice infected as adults differs from that observed in mice infected as newborns. J. Viral. 67:4369-4371
6. Berke, Z., T. Wen, S. Jin, G. Klein, and T. Dalianis. 1995. Polyomavirus persists in CD4-/-8-/- double knockout, but not in CD4-/- or CD8-/- single knockout mice. Virology 212:268-271.
7. Bright, R. K., M. H. Shearer, and R. C. Kennedy. 1994. immunization of Balbc mice with recombmant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. J. Immunol. 153:2064-2071.
8. Dalianis, T. 1990. Studies on the polyoma virus tumour-specific transplantation antigen (TSTA). Adv. Cancer Res. 55:57-85
9. Dalianis. T., G. Magnusson, Y. Ito, and G. Klein. 1982 immunization against the polyoma virus-induced turnor-specific transplantation antigen by early region mutants of the virus. J. Virol 43:772-777.
10. Dalianis, T., T, Ramqvist. and G. Klein. 1984. Studies on the polyoma-virus-induced tumor specific transplantation antigen (TSTA) - does middle or large T-antigen play a role? Int. J. Cancer 34:403-106
11. Engelhard, V. H. 1994. Structure of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 6:13-17.
12. Falk, K., O. Rötzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (London) 351:290-296.
13. Feltkamp, M. C. W., H. L. Smiths, M. P. M. Vierboom, R. P. Minnaar, B. M. de Jongh, J. W. Drijfhout, J. ter Schegget, C. J. M. Melief. and W. M. Kast. 1993. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16 transformed cells Eur. J. Immunol. 23:2242-2249.
14. Fried, M., B. E. Griffin. E. Lund, and D. L. Robberson. 1974. A study of wild type mutant and defective DNAs. Cold Spring Harbor Symp. Quant. Biol. 39:45-52.
15. Greene, M., L. Perry, E. Kinney-Thomas, and T. Benjamin. 1982. Specific thymus-derived (T) cell recognition of papova virus transformed cells. J. Immunol. 128:732-736
16. Joyce, S., and S. G. Nathenson. 1994. Methods to study peptides associated with MHC class I molecules. Curr. Opin. Immunol. 6:24-29.
17. Lathe, R., M. P. Kieny, P. Gerlinger, P. Clertant, I. Guizani. F. Cnzin, and P. Chambon. 1987 Tumor prevention and rejection with recombinant vaccinia. Nature (London) 326:378-380.
18. Ljunggren, G., H.-G. Ljunggren, and T. Dalianis. 1994. T cell subsets involved in immunity against polyoma virus-induced tumors. Virology 198:714-716.
19. Ljunggren, H.-G., and K. Karre. 1985. Host resistance directed selectively against H-2 deficient lymphoma variants Analysis of the mechanism. J. Exp. Med. 162:1745-1759
20. Lukacher, A. E., Y. Ma, J. P. Carroll, S. R. Abromson-Leman, J. C. Laning, M. E. Dorf, and T. Benjamin. 1995 Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J. Exp Med. 181:1683-1692.
21. Luthman, H., M.-G. Nilsson, and G. Magnusson. 1982 Non-contiguous segments of the polyoma genome required in as for DNA replication J. Mol. Biol. 161:533-550.
22. Miller, J. F. A. P., R. C. Ting, and L. W. Law. 1964. Influence of thymectomy on tumor induction by polyoma virus in C57BL mice. Proc. Soc. Exp. Biol. Med 116:323-328
23. Ramqvist, T., D. O. Pallas, J. DeAnda, L. Ährlund-Richter, G. Reinholdsson, T. Roberts, B. S. Schaffhausen, and T. Dalianis. 1988. Immunisation against the polyoma tumor specific transplantation antigen (TSTA) with polyoma T-antigens. Int. J Cancer 42:123-128.
24. Ramqvist, T., G. Reinholdsson, M. Carlquist, T. Bergman, and T. Dalianis. 1989. A single peptide derived from the sequence common to polyoma small-and middle-T antigen induces immunity against polyoma tumors. Virology 172:359-362.
25. Reddehase, M. J., J. B. Rothbard, and U. H. Koszinowski. 1989. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature (London) 337:651-653.
26. Reinholdsson-Ljunggren, G., T. Ramqvist, L. Ahrlund-Richter, and T. Dalianis. 1992. Immunization against polyoma tumors with synthetic peptides derived from the sequences of middle- and large-T antigens. Int J. Cancer 50:142-146.
27. Rotzschke, O., K. Falk, K. Deres, H. Schild, M. Norda, J. Metzger, G. Jung, and H.-G. Rammensee. 1990 Isolation and analysis of naturally processed viral pepudes as recognised by cytotoxic T cells Nature (London) 348:252-254.
28. Siegel, S., and N. J. Castellan. 1988 Nonparametric statistics for the behavioral sciences. 2nd ed. p. 128. McGraw-Hill, Singapore.
29. Sjogren, H. O. 1964. Studies on specific transplantation resistance to polyomavirus-induced tumors. I Transplantation resistance induced by polyomavirus infection J. Natl. Cancer Inst. 32:361-374
30. Soeda, E., J. R. Arrand, N. Smolar, J. E. Walsh, and B. E. Griffin. 1980. Coding potential and regulatory signals of the polyoma virus genome. Nature (London) 283:445-453
31. Townsend, A. R. M., J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith, and A. J. McMichael. 1986. The epuopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959-968.
32. b molecule. Nature (London) 348:213-216
33. Vandeputte, M. 1968. The effects of heterologous antilymphocytic serum on the oncogenic activity of polyoma virus. Life Sci. 7:855-565
34. Zhou, X., L. Berg, U. M. Abdel Motal, and M. Jondal. 1992 In vivo primary induction of virus-spccific CTL by immunisation with 9-mer synthetic peptides. J. Immunol Methods 153:193-200